699 related articles for article (PubMed ID: 10989197)
1. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
[TBL] [Abstract][Full Text] [Related]
2. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver.
Muench MO; Roncarolo MG; Menon S; Xu Y; Kastelein R; Zurawski S; Hannum CH; Culpepper J; Lee F; Namikawa R
Blood; 1995 Feb; 85(4):963-72. PubMed ID: 7531516
[TBL] [Abstract][Full Text] [Related]
3. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells.
Miller JS; McCullar V; Punzel M; Lemischka IR; Moore KA
Blood; 1999 Jan; 93(1):96-106. PubMed ID: 9864151
[TBL] [Abstract][Full Text] [Related]
4. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells.
Bárcena A; Muench MO; Song KS; Ohkubo T; Harrison MR
Exp Hematol; 1999 Sep; 27(9):1428-39. PubMed ID: 10480434
[TBL] [Abstract][Full Text] [Related]
5. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.
Yu H; Fehniger TA; Fuchshuber P; Thiel KS; Vivier E; Carson WE; Caligiuri MA
Blood; 1998 Nov; 92(10):3647-57. PubMed ID: 9808558
[TBL] [Abstract][Full Text] [Related]
6. High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.
Ohkubo T; Bárcena A; Smith CA; Harrison MR; Muench MO
Fetal Diagn Ther; 2001; 16(5):299-307. PubMed ID: 11509853
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
8. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver.
Bárcena A; Park SW; Banapour B; Muench MO; Mechetner E
Blood; 1996 Sep; 88(6):2013-25. PubMed ID: 8822920
[TBL] [Abstract][Full Text] [Related]
9. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
[TBL] [Abstract][Full Text] [Related]
10. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
[TBL] [Abstract][Full Text] [Related]
11. Broad distribution of colony-forming cells with erythroid, myeloid, dendritic cell, and NK cell potential among CD34(++) fetal liver cells.
Muench MO; Bárcena A
J Immunol; 2001 Nov; 167(9):4902-9. PubMed ID: 11673495
[TBL] [Abstract][Full Text] [Related]
12. Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cells.
Willems R; Henckaerts E; Lenjou M; Nijs G; Rodrigus I; Moulijn AC; Slegers H; Berneman ZN; Van Bockstaele DR
Ann Hematol; 2001 Jan; 80(1):17-25. PubMed ID: 11233770
[TBL] [Abstract][Full Text] [Related]
13. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
[TBL] [Abstract][Full Text] [Related]
14. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
[TBL] [Abstract][Full Text] [Related]
15. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture.
Sawai N; Koike K; Ito S; Mwamtemi HH; Kurokawa Y; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Miyazaki H; Kato T; Komiyama A
Blood; 1999 Jan; 93(2):509-18. PubMed ID: 9885212
[TBL] [Abstract][Full Text] [Related]
16. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells.
Toor AA; Lund TC; Miller JS
Exp Hematol; 2001 Apr; 29(4):499-506. PubMed ID: 11301190
[TBL] [Abstract][Full Text] [Related]
17. Colony-forming cells expressing high levels of CD34 are the main targets for granulocyte colony-stimulating factor and macrophage colony-stimulating factor in the human fetal liver.
Muench MO; Roncarolo MG; Rosnet O; Birnbaum D; Namikawa R
Exp Hematol; 1997 Apr; 25(4):277-87. PubMed ID: 9131001
[TBL] [Abstract][Full Text] [Related]
18. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells.
Rosler E; Brandt J; Chute J; Hoffman R
Exp Hematol; 2000 Jul; 28(7):841-52. PubMed ID: 10907646
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
20. IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells.
Crooks GM; Hao QL; Petersen D; Barsky LW; Bockstoce D
J Immunol; 2000 Sep; 165(5):2382-9. PubMed ID: 10946261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
